Figures & data
Figure 1. Pro’s and con’s of weakened ABCB1 transporter modulation in Parkinson’s disease patients under long term aspects.
Figure 2. Pro’s and con’s of strengthened ABCB1 transporter modulation in Parkinson’s disease patients.
Expert Opinion on Drug Metabolism & Toxicology
Volume 14, 2018 - Issue 2
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Leaky brain in neurological and psychiatric disorders: Drivers and consequences
Source:
SAGE Publications
Linking provided by
